Bexarotene – Possibly Hopeful in Alzheimer’s

February 11, 2012 at 8:23 pm Leave a comment

Bexarotene is currently available for the treatment of cutaneous T-cell lymphoma. It is available as a topical gel and as a capsule. Neuroscientists at Case Western Reserve University School of Medicine in Cleveland are involved in research involving this medication. Upon studies in mice, it was found that bexarotene was responsible for lowering soluble amyloid levels. The medication also removed amyloid plaques from the brain. This is wonderful information for the Alzheimer’s community. There is a lot of excitement, but the researchers have stressed that the study is at an early stage, and has not been done on humans yet.

Advertisements

Entry filed under: Alzheimer. Tags: .

New Criteria for Alzheimer’s Disease Nicotine Patch May Improve Cognitive Impairment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Total Visits

  • 7,486 visits

%d bloggers like this: